Thursday, March 3, 2022

< + > WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron

The WHO panel is also evaluating data for Pfizer’s antiviral pill, paxlovid, and a widely available antidepressant, fluvoxamine, to treat Covid-19.

No comments:

Post a Comment

< + > Beyond the Science by Gary Zammit – Life Sciences Today Podcast Episode 46

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Gary Zammit, PhD,...